Acro Biomedical Co., Ltd.
ACBM· OTC
ACBMAcro Biomedical Co., Ltd.
Filed Dec 16, 2016 · 10-K · 77 days after period end · 0001640334-16-002238
derived · Computed from the longer spans the company filed.
| Metric | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures |
|---|---|---|
| Net Income | -$6.13K | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Acro Biomedical Co., Ltd. · CIK 1622996 · Engraved from SEC EDGAR
ended Sep 30, 2016 · filed Dec 16, 2016 · 77 d after period end
